Inspire Drops Bilastine, but all Eyes are on Denufosol Jan. 15, 2008 By Trista Morrison Inspire Pharmaceuticals Inc.'s decision to discontinue development of the oral antihistamine bilastine for allergic rhinitis was "no surprise" to Cowen & Co. analyst Ian Sanderson. (BioWorld Today)Read More
Report from Europe: Drug delivery made simple by firm’s osmostic pressure tech Jan. 15, 2008 By John Brosky
RSS